VAT dropped by about 18% over 52 weeks vs placebo
These findings may ultimately expand the indications for GLP-1RA therapy and solidify their role in precision CV risk reduction, for example in different subphenotypes of prediabetes and T2D
Related Peptides View all Semaglutide (GLP-1) Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the incretin hormone GLP-1, regulating blood glucose levels, appetite, and body weight through multiple metabolic pathways
Talk to your doctor about the best treatment for RA
after a median of 12.4 years of monitoring, those in the highest quartiles of baseline CAC scores and carotid artery plaque burden had 15% and 23% higher risk of death for any reason, respectively, compared with those in the lowest quartiles
Such early identification is crucial for directing timely interventions that can alleviate the harmful effects of oxidative stress on spermatozoa and enhance fertility prospects